FDA 483 - Texoma Regional Blood Center - May 03, 2019

An FDA inspection of Texoma Regional Blood Center in Sherman, TX, revealed significant deficiencies in donor eligibility and record-keeping practices. The firm failed to properly defer unsuitable donors, resulting in the distribution and transfusion of potentially unsafe blood components. Additionally, processing steps for blood units were not concurrently documented, hindering traceability.